SynthesisJAMA network open2022

Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis: A Meta-analysis.

Avi Bitterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.